Fractional CMO for Healthcare and Health Tech Companies
By Mark Gabrielli · Fractional CMO & COO · Last updated: May 2026Your product works and your pilots prove it. The problem is turning a few champions into signed enterprise contracts while every claim you publish has to survive legal review and every buyer has three bosses.
A fractional CMO for a healthcare company owns go-to-market part time: which settings to sell into, what you can safely claim, and a demand engine that reaches the clinical champion, the finance team and IT security in the same quarter. Most engagements cost $5,000 to $20,000 a month, and the first 30 days are a diagnostic, not a campaign.
When healthcare companies bring in a fractional CMO
The call usually starts with one of these situations:
- Pilots that never convert. Two or three sites love the product, but there is no repeatable way to reach the next twenty.
- A clinician founder who is still the only closer. Physicians trust a physician, so every deal waits on one calendar.
- An agency that bought traffic, not meetings. Sometimes it also produced a claim that compliance had to pull back.
- A board asking for enterprise growth while the team is still selling one practice at a time.
Why the standard B2B playbook breaks in healthcare
A hospital purchase is a committee decision. The clinical champion wants outcomes, the value analysis committee wants cost evidence, IT wants a security review and a business associate agreement, and the CFO wants payback. Marketing that speaks to one of them stalls with the other three.
Claims are also constrained. A device can only be promoted for its cleared indications, outcome claims need evidence you can hand to a skeptical reviewer, and tracking pixels on patient-facing pages are now a privacy question, not just an analytics one. The job is to market hard inside those lines, with your regulatory counsel in the loop, rather than pretend they are not there.
What Mark brings to a healthcare engagement
Mark Gabrielli is a Certified Surgical Technologist (2012) who worked the instrument table across six surgical specialties, including cardiovascular and orthopedic surgery. He has held HIPAA responsibility at the CMO level for a healthcare AI platform. He knows how clinicians judge a vendor because he has stood in the room where the product gets used.
Healthcare SaaS, $4M ARR at the start: grew to $16M ARR in 18 months. The ICP was rebuilt around hospital groups instead of individual practices, an account-based program targeted 120 named health systems, and EHR integration partners became 30% of new ARR.
Digital health platform: 3x pipeline in six months with zero compliance issues, after a previous agency had produced no pipeline and a compliance flag. First enterprise contract signed in month seven.
Sources: MarkCMO case studies and results. Client names are kept confidential.
Your first 90 days
| Window | What happens | What you have at the end |
|---|---|---|
| Days 1 to 30 | Claims inventory with your regulatory lead, ICP by care setting, buying-committee map, audit of tracking on patient-facing pages, review of every channel you pay for. | An approved claims list, a ranked target list and a stop-doing list. |
| Days 31 to 60 | Evidence library (outcomes, case studies, an ROI model a value analysis committee can use), messaging for each stakeholder, partner and marketplace review. | Sales assets for every seat at the table. |
| Days 61 to 90 | Named-account program live, conference and specialty-society plan, weekly pipeline review with sales. | Meetings with economic buyers and a forecast you can defend. |
See what your first 90 days would look like
Bring your current pipeline and your toughest compliance constraint. You will leave with the first two things to fix, whether or not we work together.
Book a free 30-minute strategy callThe numbers we manage in healthcare
| Metric | Why it matters here |
|---|---|
| Committee coverage | Accounts where you have engaged clinical, finance and IT contacts, not just a champion. |
| Pilot to contract rate | The clearest sign that proof is landing with the people who sign. |
| Sales cycle by setting | Health systems, ambulatory groups and practices move at very different speeds. |
| Security review time | A slow questionnaire quietly kills quarters. Marketing can pre-answer it. |
| Pipeline by source | Shows whether partners, events or content actually create meetings. |
What it costs
Most fractional CMO engagements cost $5,000 to $20,000 a month, and lighter early-stage scopes run $3,000 to $6,000. The full breakdown is on our fractional CMO cost guide. A full-time healthcare CMO adds salary, equity and a long search before any of the work starts.
What healthcare founders ask before they book
"Our market is too regulated for real marketing." It is regulated, not closed. The companies that win publish more evidence, not less, and they get it approved before launch instead of after.
"We need someone full time." Maybe later. A fractional CMO builds the system and the team first, then helps you hire the right full-time leader when the engine justifies it.
Healthcare fractional CMO FAQ
What does a fractional CMO do for a healthcare company?
A fractional CMO leads your go-to-market part time. That means choosing the care settings and accounts to pursue, building messaging for each member of the buying committee, keeping claims inside regulatory limits with your counsel, and running the programs that create meetings: account-based outreach, evidence content, partners and events. You get executive ownership of pipeline without a full-time executive salary.
How much does a fractional CMO cost for a healthcare company?
Most fractional CMO engagements cost $5,000 to $20,000 a month, depending on scope and time. Lighter early-stage scopes run $3,000 to $6,000 a month. Healthcare work often sits in the middle of the range because claims review and multi-stakeholder selling add work. See the cost guide for the full breakdown.
Can a fractional CMO keep our marketing HIPAA and FDA compliant?
A fractional CMO designs marketing to work inside HIPAA, FDA and FTC limits, for example by building an approved claims list, keeping promotion to cleared indications and auditing tracking on patient-facing pages. That is not a substitute for legal review. The right setup is your regulatory counsel approving claims and the CMO building a program that does not need constant rescue.
How long until a healthcare company sees results?
Expect the first 30 days to be diagnostic work, with early pipeline signals between days 60 and 90 as named-account outreach and evidence content go live. Signed enterprise contracts follow your sales cycle, which is often several months longer. In one digital health engagement the pipeline tripled within six months and the first enterprise contract was signed in month seven.
Talk to a CMO who has worked inside healthcare
Tell Mark where deals stall today. In 30 minutes you will know whether the problem is targeting, proof, compliance or follow-through, and what to do about it first.
Book a Free Strategy Call